100509,1,Admission,O
100509,1,Date,O
100509,1,:,O
100509,1,[,O
100509,1,**2172-8-25**,O
100509,1,],O
100509,1,Discharge,O
100509,1,Date,O
100509,1,:,O
100509,1,[,O
100509,1,**2172-9-6**,O
100509,1,],O
100509,1,Date,O
100509,1,of,O
100509,1,Birth,O
100509,1,:,O
100509,1,[,O
100509,1,**2114-3-8**,O
100509,1,],O
100509,1,Sex,O
100509,1,:,O
100509,1,F,O
100509,1,Service,O
100509,1,:,O
100509,1,MEDICINE,O
100509,1,Allergies,O
100509,1,:,O
100509,1,Patient,O
100509,1,recorded,O
100509,1,as,O
100509,1,having,O
100509,1,No,O
100509,1,Known,O
100509,1,Allergies,O
100509,1,to,O
100509,1,Drugs,O
100509,1,Attending,O
100509,1,:,O
100509,1,[,O
100509,1,**First,O
100509,1,Name3,O
100509,1,(,O
100509,1,LF,O
100509,1,),O
100509,1,3984**,O
100509,1,],O
100509,1,Chief,O
100509,1,Complaint,O
100509,1,:,O
100509,1,dyspnea,O
100509,1,",",O
100509,1,hoarseness,O
100509,1,",",O
100509,1,and,O
100509,1,cough,O
100509,1,Major,O
100509,1,Surgical,O
100509,1,or,O
100509,1,Invasive,O
100509,1,Procedure,O
100509,1,:,O
100509,1,Bronchoscopy,O
100509,1,x2,O
100509,1,Tracheal,O
100509,1,Y-stent,O
100509,1,placement,O
100509,1,[,O
100509,1,**2172-8-25**,O
100509,1,],O
100509,1,Pigtail,O
100509,1,catheter,O
100509,1,placement,O
100509,1,(,O
100509,1,right,O
100509,1,),O
100509,1,[,O
100509,1,**2172-8-25**,O
100509,1,],O
100509,1,for,O
100509,1,pleural,O
100509,1,effusion,O
100509,1,Intubation,O
100509,1,[,O
100509,1,**2172-8-25**,O
100509,1,],O
100509,1,",",O
100509,1,re-intubated,O
100509,1,[,O
100509,1,**2172-8-26**,O
100509,1,],O
100509,1,after,O
100509,1,attempted,O
100509,1,extubation,O
100509,1,Chest,O
100509,1,tube,O
100509,1,placement,O
100509,1,(,O
100509,1,right,O
100509,1,),O
100509,1,[,O
100509,1,**2172-8-26**,O
100509,1,],O
100509,1,for,O
100509,1,pneumothorax,O
100509,1,Radiation,O
100509,1,therapy,O
100509,1,x2,O
100509,1,Chemotherapy,B-Drug
100509,1,x3days,O
100509,1,Lumbar,O
100509,1,puncture,O
100509,1,[,O
100509,1,**2172-9-3**,O
100509,1,],O
100509,1,History,O
100509,1,of,O
100509,1,Present,O
100509,1,Illness,O
100509,1,:,O
100509,1,58,O
100509,1,year-old,O
100509,1,female,O
100509,1,",",O
100509,1,60,O
100509,1,pack-year,O
100509,1,smoker,O
100509,1,",",O
100509,1,with,O
100509,1,dyspnea,O
100509,1,",",O
100509,1,hoarseness,O
100509,1,",",O
100509,1,and,O
100509,1,cough,O
100509,1,x1,O
100509,1,month,O
100509,1,admitted,O
100509,1,to,O
100509,1,[,O
100509,1,**Hospital1,O
100509,1,18**,O
100509,1,],O
100509,1,SICU,O
100509,1,[,O
100509,1,**2172-8-25**,O
100509,1,],O
100509,1,after,O
100509,1,found,O
100509,1,to,O
100509,1,have,O
100509,1,large,O
100509,1,mediastinal,O
100509,1,mass,O
100509,1,",",O
100509,1,today,O
100509,1,found,O
100509,1,to,O
100509,1,be,O
100509,1,poorly-differentiated,O
100509,1,carcinoma,O
100509,1,",",O
100509,1,suspected,O
100509,1,small,O
100509,1,cell,O
100509,1,.,O
100509,1,On,O
100509,1,initial,O
100509,1,evaluation,O
100509,1,",",O
100509,1,patient,O
100509,1,was,O
100509,1,found,O
100509,1,to,O
100509,1,have,O
100509,1,3mm,O
100509,1,opening,O
100509,1,of,O
100509,1,distal,O
100509,1,trachea,O
100509,1,secondary,O
100509,1,to,O
100509,1,external,O
100509,1,compression,O
100509,1,from,O
100509,1,mediastinal,O
100509,1,mass,O
100509,1,",",O
100509,1,RUL,O
100509,1,mass,O
100509,1,",",O
100509,1,RUL,O
100509,1,collapse,O
100509,1,",",O
100509,1,and,O
100509,1,clinical,O
100509,1,findings,O
100509,1,consistent,O
100509,1,with,O
100509,1,SVC,O
100509,1,sydrome,O
100509,1,.,O
100509,1,Y-stent,O
100509,1,was,O
100509,1,placed,O
100509,1,that,O
100509,1,evening,O
100509,1,",",O
100509,1,in,O
100509,1,addition,O
100509,1,to,O
100509,1,Pigtail,O
100509,1,catheter,O
100509,1,for,O
100509,1,right-sided,O
100509,1,effusion,O
100509,1,.,O
100509,1,Patient,O
100509,1,remained,O
100509,1,intubated,O
100509,1,following,O
100509,1,surgery,O
100509,1,",",O
100509,1,on,O
100509,1,paralytics,O
100509,1,due,O
100509,1,to,O
100509,1,low-lying,O
100509,1,ET,O
100509,1,tube,O
100509,1,and,O
100509,1,small,O
100509,1,volume,O
100509,1,bleeding,O
100509,1,after,O
100509,1,endobronchial,O
100509,1,biopsy,O
100509,1,.,O
100509,1,On,O
100509,1,[,O
100509,1,**2172-8-26**,O
100509,1,],O
100509,1,",",O
100509,1,extubated,O
100509,1,was,O
100509,1,attempted,O
100509,1,.,O
100509,1,Patient,O
100509,1,was,O
100509,1,reintubated,O
100509,1,within,O
100509,1,10,O
100509,1,minutes,O
100509,1,due,O
100509,1,to,O
100509,1,neurological,O
100509,1,unresponsiveness,O
100509,1,",",O
100509,1,hypoxia,O
100509,1,(,O
100509,1,O2,O
100509,1,saturation,O
100509,1,80s,O
100509,1,),O
100509,1,",",O
100509,1,and,O
100509,1,hemodynamic,O
100509,1,instability,O
100509,1,.,O
100509,1,She,O
100509,1,was,O
100509,1,found,O
100509,1,to,O
100509,1,have,O
100509,1,a,O
100509,1,right,O
100509,1,pneumothorax,O
100509,1,",",O
100509,1,which,O
100509,1,improved,O
100509,1,with,O
100509,1,subsequent,O
100509,1,placement,O
100509,1,of,O
100509,1,chest,O
100509,1,tube,O
100509,1,.,O
100509,1,Patient,O
100509,1,was,O
100509,1,also,O
100509,1,noted,O
100509,1,to,O
100509,1,have,O
100509,1,pericardial,O
100509,1,effusion,O
100509,1,;,O
100509,1,given,O
100509,1,absence,O
100509,1,of,O
100509,1,physiologic,O
100509,1,tamponade,O
100509,2,",",O
100509,2,cardiology,O
100509,2,decided,O
100509,2,against,O
100509,2,pericardiocentesis,O
100509,2,.,O
100509,2,.,O
100509,2,Hospital,O
100509,2,course,O
100509,2,also,O
100509,2,complicated,O
100509,2,by,O
100509,2,hyponatremia,O
100509,2,on,O
100509,2,admission,O
100509,2,(,O
100509,2,Na,O
100509,2,118,O
100509,2,),O
100509,2,attributed,O
100509,2,to,O
100509,2,SIADH,O
100509,2,and,O
100509,2,improved,O
100509,2,with,O
100509,2,fluid,O
100509,2,restriction,O
100509,2,(,O
100509,2,Na,O
100509,2,126,O
100509,2,),O
100509,2,.,O
100509,2,Also,O
100509,2,with,O
100509,2,hypotension,O
100509,2,(,O
100509,2,sBP,O
100509,2,90s,O
100509,2,),O
100509,2,following,O
100509,2,reintubation,O
100509,2,on,O
100509,2,[,O
100509,2,**2172-8-26**,O
100509,2,],O
100509,2,.,O
100509,2,Given,O
100509,2,hyperkalemia,O
100509,2,",",O
100509,2,hyponatremia,O
100509,2,adrenal,O
100509,2,insufficiency,O
100509,2,was,O
100509,2,suspected,O
100509,2,;,O
100509,2,evaluated,O
100509,2,by,O
100509,2,endocrine,O
100509,2,team,O
100509,2,who,O
100509,2,recommended,O
100509,2,stress,O
100509,2,dose,O
100509,2,steroids,B-Drug
100509,2,pending,O
100509,2,further,O
100509,2,evaluation,O
100509,2,of,O
100509,2,etiology,O
100509,2,of,O
100509,2,hypotension,O
100509,2,.,O
100509,2,Also,O
100509,2,with,O
100509,2,non-anion,O
100509,2,gap,O
100509,2,metabolic,O
100509,2,acidosis,O
100509,2,",",O
100509,2,transient,O
100509,2,hypothermia,O
100509,2,(,O
100509,2,T,O
100509,2,95,O
100509,2,[,O
100509,2,**2172-8-26**,O
100509,2,],O
100509,2,),O
100509,2,of,O
100509,2,unknown,O
100509,2,etiology,O
100509,2,.,O
100509,2,.,O
100509,2,Per,O
100509,2,report,O
100509,2,",",O
100509,2,patient,O
100509,2,has,O
100509,2,done,O
100509,2,well,O
100509,2,today,O
100509,2,.,O
100509,2,She,O
100509,2,remains,O
100509,2,intubated,O
100509,2,",",O
100509,2,on,O
100509,2,pressure,O
100509,2,support,O
100509,2,.,O
100509,2,Given,O
100509,2,the,O
100509,2,above,O
100509,2,pathology,O
100509,2,results,O
100509,2,",",O
100509,2,patient,O
100509,2,is,O
100509,2,transferred,O
100509,2,to,O
100509,2,the,O
100509,2,medical,O
100509,2,ICU,O
100509,2,(,O
100509,2,[,O
100509,2,**Hospital,O
100509,2,Ward,O
100509,2,Name,O
100509,2,332**,O
100509,2,],O
100509,2,),O
100509,2,for,O
100509,2,radiation,O
100509,2,therapy,O
100509,2,.,O
100509,2,.,O
100509,2,On,O
100509,2,arrival,O
100509,2,to,O
100509,2,the,O
100509,2,[,O
100509,2,**Hospital,O
100509,2,332**,O
100509,2,],O
100509,2,medical,O
100509,2,ICU,O
100509,2,",",O
100509,2,patient,O
100509,2,is,O
100509,2,intubated,O
100509,2,",",O
100509,2,sedated,O
100509,2,",",O
100509,2,and,O
100509,2,unable,O
100509,2,to,O
100509,2,provide,O
100509,2,history,O
100509,2,.,O
100509,2,Past,O
100509,2,Medical,O
100509,2,History,O
100509,2,:,O
100509,2,Hypertension,O
100509,2,s/p,O
100509,2,cerebral,O
100509,2,sneurysm,O
100509,2,repair,O
100509,2,x3,O
100509,2,GERD,O
100509,2,Social,O
100509,2,History,O
100509,2,:,O
100509,2,Per,O
100509,2,review,O
100509,2,of,O
100509,2,records,O
100509,2,",",O
100509,2,60,O
100509,2,pack-year,O
100509,2,history,O
100509,2,Family,O
100509,2,History,O
100509,2,:,O
100509,2,Unable,O
100509,2,to,O
100509,2,obtain,O
100509,2,.,O
100509,2,Physical,O
100509,2,Exam,O
100509,2,:,O
100509,2,On,O
100509,2,[,O
100509,2,**Hospital,O
100509,2,Unit,O
100509,2,Name,O
100509,2,153**,O
100509,2,],O
100509,2,admission,O
100509,2,[,O
100509,2,**2172-8-27**,O
100509,2,],O
100509,2,:,O
100509,2,96.0,O
100509,2,",",O
100509,2,103,O
100509,2,",",O
100509,2,120/68,O
100509,2,",",O
100509,2,13,O
100509,2,",",O
100509,2,97,O
100509,2,%,O
100509,2,[,O
100509,2,PS,O
100509,2,14/5,O
100509,2,50,O
100509,2,%,O
100509,2,],O
100509,2,General,O
100509,2,:,O
100509,2,Intubated,O
100509,2,",",O
100509,2,sedated,O
100509,2,",",O
100509,2,not,O
100509,2,responsive,O
100509,2,to,O
100509,2,verbal,O
100509,2,stimuli,O
100509,2,;,O
100509,2,swelling,O
100509,2,of,O
100509,2,head,O
100509,2,",",O
100509,2,neck,O
100509,2,",",O
100509,2,and,O
100509,2,upper,O
100509,2,extremities,O
100509,2,;,O
100509,2,wasting,O
100509,2,of,O
100509,2,lower,O
100509,2,extremities,O
100509,2,Skin,O
100509,2,:,O
100509,2,Mottled,O
100509,2,at,O
100509,2,arms,O
100509,2,and,O
100509,2,superior,O
100509,2,to,O
100509,2,nipple,O
100509,2,line,O
100509,2,;,O
100509,2,telangiectasias,O
100509,2,on,O
100509,2,chest,O
100509,2,wall,O
100509,2,HEENT,O
100509,2,:,O
100509,2,Temporal,O
100509,2,wasting,O
100509,2,;,O
100509,2,pupils,O
100509,2,symmetric,O
100509,2,",",O
100509,2,minimal,O
100509,2,reactivity,O
100509,2,to,O
100509,2,light,O
100509,2,;,O
100509,2,sclerae,O
100509,2,anicetric,O
100509,2,;,O
100509,2,scleral,O
100509,2,edema,O
100509,2,;,O
100509,2,dry,O
100509,2,mucous,O
100509,2,membranes,O
100509,2,Neck,O
100509,2,:,O
100509,2,Large,O
100509,2,;,O
100509,2,unable,O
100509,2,to,O
100509,2,appreciate,O
100509,2,neck,O
100509,2,veins,O
100509,2,secondary,O
100509,2,to,O
100509,2,swelling,O
100509,2,;,O
100509,2,right,O
100509,2,anterior,O
100509,2,chain,O
100509,2,palpable,O
100509,2,lymph,O
100509,3,node,O
100509,3,Chest,O
100509,3,:,O
100509,3,Right,O
100509,3,chest,O
100509,3,tube,O
100509,3,",",O
100509,3,pigtail,O
100509,3,catheter,O
100509,3,in,O
100509,3,place,O
100509,3,Lungs,O
100509,3,:,O
100509,3,Upper,O
100509,3,airway,O
100509,3,noise,O
100509,3,;,O
100509,3,by,O
100509,3,anterior,O
100509,3,ausculation,O
100509,3,",",O
100509,3,few,O
100509,3,expiratory,O
100509,3,wheezes,O
100509,3,diffusely,O
100509,3,;,O
100509,3,breath,O
100509,3,sounds,O
100509,3,appreciable,O
100509,3,in,O
100509,3,all,O
100509,3,lung,O
100509,3,fields,O
100509,3,CV,O
100509,3,:,O
100509,3,Tachycardic,O
100509,3,;,O
100509,3,regular,O
100509,3,rhythm,O
100509,3,;,O
100509,3,pronounced,O
100509,3,S2,O
100509,3,at,O
100509,3,apex,O
100509,3,;,O
100509,3,I/VI,O
100509,3,early,O
100509,3,systolic,O
100509,3,murmur,O
100509,3,at,O
100509,3,left,O
100509,3,LLSB,O
100509,3,;,O
100509,3,unable,O
100509,3,to,O
100509,3,assess,O
100509,3,pulsus,O
100509,3,paradoxus,O
100509,3,given,O
100509,3,quiet,O
100509,3,Korsakoff,O
100509,3,sounds,O
100509,3,Abdomen,O
100509,3,:,O
100509,3,Hypoactive,O
100509,3,bowel,O
100509,3,sounds,O
100509,3,;,O
100509,3,soft,O
100509,3,",",O
100509,3,non-distended,O
100509,3,GU,O
100509,3,:,O
100509,3,Foley,O
100509,3,Ext,O
100509,3,:,O
100509,3,Right,O
100509,3,DP,O
100509,3,1+,O
100509,3,",",O
100509,3,left,O
100509,3,DP,O
100509,3,appreciated,O
100509,3,with,O
100509,3,Doppler,O
100509,3,;,O
100509,3,no,O
100509,3,lower,O
100509,3,extremity,O
100509,3,edema,O
100509,3,;,O
100509,3,upper,O
100509,3,extremity,O
100509,3,nonpitting,O
100509,3,edema,O
100509,3,Pertinent,O
100509,3,Results,O
100509,3,:,O
100509,3,On,O
100509,3,admission,O
100509,3,[,O
100509,3,**2172-8-26**,O
100509,3,],O
100509,3,:,O
100509,3,WBC-11.1*,O
100509,3,RBC-3.47*,O
100509,3,Hgb-10.9*,O
100509,3,Hct-31.9*,O
100509,3,MCV-92,O
100509,3,MCH-31.5,O
100509,3,MCHC-34.2,O
100509,3,RDW-12.5,O
100509,3,Plt,O
100509,3,Ct-393,O
100509,3,Glucose-112*,O
100509,3,UreaN-9,O
100509,3,Creat-0.8,O
100509,3,Na-118*,O
100509,3,K-4.8,O
100509,3,Cl-82*,O
100509,3,HCO3-24,O
100509,3,AnGap-17,O
100509,3,ALT-7,O
100509,3,AST-21,O
100509,3,LD,O
100509,3,(,O
100509,3,LDH,O
100509,3,),O
100509,3,-584*,O
100509,3,AlkPhos-75,O
100509,3,TotBili-0.2,O
100509,3,Cortsol-25.7*,O
100509,3,Hgb-13.5,O
100509,3,calcHCT-41,O
100509,3,O2,O
100509,3,Sat-82,O
100509,3,.,O
100509,3,Imaging,O
100509,3,:,O
100509,3,[,O
100509,3,**8-25**,O
100509,3,],O
100509,3,CT,O
100509,3,Chest,O
100509,3,without,O
100509,3,contrast,O
100509,3,:,O
100509,3,1,O
100509,3,.,O
100509,3,Large,O
100509,3,mediastinal,O
100509,3,mass,O
100509,3,causes,O
100509,3,narrowing,O
100509,3,of,O
100509,3,the,O
100509,3,right,O
100509,3,pulmonary,O
100509,3,artery,O
100509,3,",",O
100509,3,superior,O
100509,3,vena,O
100509,3,cava,O
100509,3,",",O
100509,3,and,O
100509,3,trachea,O
100509,3,and,O
100509,3,occlusion,O
100509,3,of,O
100509,3,the,O
100509,3,pulmonary,O
100509,3,artery,O
100509,3,supplying,O
100509,3,the,O
100509,3,right,O
100509,3,upper,O
100509,3,lobe,O
100509,3,in,O
100509,3,addition,O
100509,3,to,O
100509,3,the,O
100509,3,right,O
100509,3,upper,O
100509,3,lobe,O
100509,3,bronchus,O
100509,3,.,O
100509,3,These,O
100509,3,findings,O
100509,3,are,O
100509,3,most,O
100509,3,concerning,O
100509,3,for,O
100509,3,a,O
100509,3,primary,O
100509,3,lung,O
100509,3,carcinoma,O
100509,3,.,O
100509,3,2,O
100509,3,.,O
100509,3,Right,O
100509,3,upper,O
100509,3,lobe,O
100509,3,collapse,O
100509,3,with,O
100509,3,nonenhancing,O
100509,3,lung,O
100509,3,parenchyma,O
100509,3,.,O
100509,3,Tumor,O
100509,3,involvement,O
100509,3,can,O
100509,3,not,O
100509,3,be,O
100509,3,excluded,O
100509,3,.,O
100509,3,Atelectasis,O
100509,3,of,O
100509,3,the,O
100509,3,right,O
100509,3,lower,O
100509,3,and,O
100509,3,middle,O
100509,3,lobe,O
100509,3,.,O
100509,3,3,O
100509,3,.,O
100509,3,Large,O
100509,3,right,O
100509,3,pleural,O
100509,3,effusion,O
100509,3,.,O
100509,3,.,O
100509,3,[,O
100509,3,**8-25**,O
100509,3,],O
100509,3,Tracheal,O
100509,3,mass,O
100509,3,tissue,O
100509,3,pathology,O
100509,3,:,O
100509,3,Immunohistochemical,O
100509,3,studies,O
100509,3,show,O
100509,3,that,O
100509,3,tumor,O
100509,3,cells,O
100509,3,are,O
100509,3,positively,O
100509,3,stained,O
100509,3,by,O
100509,3,TTF-1,O
100509,3,and,O
100509,3,CK7,O
100509,3,;,O
100509,3,they,O
100509,3,are,O
100509,3,negative,O
100509,3,for,O
100509,3,CK20,O
100509,3,",",O
100509,3,chromogranin,O
100509,3,",",O
100509,3,and,O
100509,3,synaptophysin,O
100509,3,.,O
100509,3,The,O
100509,3,tumor,O
100509,3,shows,O
100509,3,areas,O
100509,3,of,O
100509,3,necrosis,O
100509,3,",",O
100509,3,extensive,O
100509,3,apoptosis,O
100509,3,and,O
100509,3,focal,O
100509,3,lymphatic,O
100509,3,vascular,O
100509,3,invasion,O
100509,3,;,O
100509,3,some,O
100509,3,areas,O
100509,3,the,O
100509,3,tumor,O
100509,3,cell,O
100509,3,size,O
100509,3,approaching,O
100509,3,that,O
100509,3,of,O
100509,3,a,O
100509,3,small,O
100509,3,cell,O
100509,3,carcinoma,O
100509,3,",",O
100509,3,but,O
100509,3,much,O
100509,3,of,O
100509,3,the,O
100509,3,tumor,O
100509,3,has,O
100509,4,larger,O
100509,4,nuclei,O
100509,4,.,O
100509,4,Overall,O
100509,4,",",O
100509,4,the,O
100509,4,tumor,O
100509,4,probably,O
100509,4,fits,O
100509,4,into,O
100509,4,the,O
100509,4,spectrum,O
100509,4,of,O
100509,4,a,O
100509,4,small,O
100509,4,cell,O
100509,4,carcinoma,O
100509,4,of,O
100509,4,lung,O
100509,4,.,O
100509,4,.,O
100509,4,[,O
100509,4,**8-26**,O
100509,4,],O
100509,4,Pleural,O
100509,4,fluid,O
100509,4,cytology,O
100509,4,:,O
100509,4,Rare,O
100509,4,groups,O
100509,4,of,O
100509,4,epithelioid,O
100509,4,cells,O
100509,4,",",O
100509,4,too,O
100509,4,few,O
100509,4,to,O
100509,4,characterize,O
100509,4,further,O
100509,4,.,O
100509,4,By,O
100509,4,immunohistochemistry,O
100509,4,:,O
100509,4,mesothelial,O
100509,4,cells,O
100509,4,stain,O
100509,4,for,O
100509,4,calretinin,O
100509,4,and,O
100509,4,WT-1,O
100509,4,.,O
100509,4,Epithelial,O
100509,4,markers,O
100509,4,[,O
100509,4,**Last,O
100509,4,Name,O
100509,4,(,O
100509,4,un,O
100509,4,),O
100509,4,**,O
100509,4,],O
100509,4,-31,O
100509,4,",",O
100509,4,CEA,O
100509,4,",",O
100509,4,and,O
100509,4,B72.3,O
100509,4,are,O
100509,4,negative,O
100509,4,.,O
100509,4,Rare,O
100509,4,cells,O
100509,4,are,O
100509,4,highlighted,O
100509,4,by,O
100509,4,TTF-1,O
100509,4,;,O
100509,4,however,O
100509,4,",",O
100509,4,these,O
100509,4,cells,O
100509,4,are,O
100509,4,not,O
100509,4,cytologically,O
100509,4,atypical,O
100509,4,and,O
100509,4,may,O
100509,4,represent,O
100509,4,non-specific,O
100509,4,reactivity,O
100509,4,.,O
100509,4,.,O
100509,4,[,O
100509,4,**8-26**,O
100509,4,],O
100509,4,EKG,O
100509,4,:,O
100509,4,Sinus,O
100509,4,tachycardia,O
100509,4,.,O
100509,4,Low,O
100509,4,QRS,O
100509,4,voltage,O
100509,4,in,O
100509,4,limb,O
100509,4,leads,O
100509,4,.,O
100509,4,No,O
100509,4,previous,O
100509,4,tracing,O
100509,4,available,O
100509,4,for,O
100509,4,comparison,O
100509,4,.,O
100509,4,.,O
100509,4,[,O
100509,4,**8-26**,O
100509,4,],O
100509,4,Echo,O
100509,4,:,O
100509,4,The,O
100509,4,left,O
100509,4,atrium,O
100509,4,and,O
100509,4,right,O
100509,4,atrium,O
100509,4,are,O
100509,4,normal,O
100509,4,in,O
100509,4,cavity,O
100509,4,size,O
100509,4,.,O
100509,4,There,O
100509,4,is,O
100509,4,mild,O
100509,4,symmetric,O
100509,4,left,O
100509,4,ventricular,O
100509,4,hypertrophy,O
100509,4,with,O
100509,4,normal,O
100509,4,cavity,O
100509,4,size,O
100509,4,and,O
100509,4,regional/global,O
100509,4,systolic,O
100509,4,function,O
100509,4,(,O
100509,4,LVEF,O
100509,4,>,O
100509,4,55,O
100509,4,%,O
100509,4,),O
100509,4,.,O
100509,4,Right,O
100509,4,ventricular,O
100509,4,chamber,O
100509,4,size,O
100509,4,and,O
100509,4,free,O
100509,4,wall,O
100509,4,motion,O
100509,4,are,O
100509,4,normal,O
100509,4,.,O
100509,4,The,O
100509,4,aortic,O
100509,4,valve,O
100509,4,leaflets,O
100509,4,(,O
100509,4,3,O
100509,4,),O
100509,4,appear,O
100509,4,structurally,O
100509,4,normal,O
100509,4,with,O
100509,4,good,O
100509,4,leaflet,O
100509,4,excursion,O
100509,4,and,O
100509,4,no,O
100509,4,aortic,O
100509,4,regurgitation,O
100509,4,.,O
100509,4,The,O
100509,4,mitral,O
100509,4,valve,O
100509,4,appears,O
100509,4,structurally,O
100509,4,normal,O
100509,4,with,O
100509,4,trivial,O
100509,4,mitral,O
100509,4,regurgitation,O
100509,4,.,O
100509,4,There,O
100509,4,is,O
100509,4,a,O
100509,4,small,O
100509,4,to,O
100509,4,moderate,O
100509,4,sized,O
100509,4,",",O
100509,4,primarily,O
100509,4,anterior,O
100509,4,pericardial,O
100509,4,effusion,O
100509,4,without,O
100509,4,right,O
100509,4,ventricular,O
100509,4,diastolic,O
100509,4,collapse,O
100509,4,.,O
100509,4,IMPRESSION,O
100509,4,:,O
100509,4,Suboptimal,O
100509,4,image,O
100509,4,quality,O
100509,4,.,O
100509,4,Mild-moderate,O
100509,4,",",O
100509,4,primarily,O
100509,4,anterior,O
100509,4,pericardial,O
100509,4,effusion,O
100509,4,.,O
100509,4,Mild,O
100509,4,symmetric,O
100509,4,left,O
100509,4,ventricular,O
100509,4,hypertrophy,O
100509,4,with,O
100509,4,preserved,O
100509,4,global,O
100509,4,and,O
100509,4,regional,O
100509,4,biventricular,O
100509,4,systolic,O
100509,4,function,O
100509,4,.,O
100509,4,If,O
100509,4,clinically,O
100509,4,indicated,O
100509,4,",",O
100509,4,a,O
100509,4,follow-up,O
100509,4,study,O
100509,4,is,O
100509,4,suggested,O
100509,4,.,O
100509,4,.,O
100509,4,[,O
100509,4,**8-27**,O
100509,4,],O
100509,4,CT,O
100509,4,chest/abdomen/pelvis,O
100509,4,with,O
100509,4,and,O
100509,4,without,O
100509,4,contrast,O
100509,4,:,O
100509,4,1,O
100509,4,.,O
100509,4,Vascular,O
100509,4,findings,O
100509,4,unchanged,O
100509,4,from,O
100509,4,[,O
100509,4,**2172-8-25**,O
100509,4,],O
100509,4,.,O
100509,4,Narrowing,O
100509,4,of,O
100509,4,SVC,O
100509,4,and,O
100509,4,left,O
100509,4,brachiocephalic,O
100509,4,vein,O
100509,4,by,O
100509,4,large,O
100509,4,mediastinal,O
100509,4,mass,O
100509,4,.,O
100509,4,The,O
100509,4,SVC,O
100509,4,is,O
100509,4,narrowed,O
100509,4,to,O
100509,4,approximately,O
100509,4,5,O
100509,4,mm,O
100509,4,over,O
100509,4,a,O
100509,4,region,O
100509,4,extending,O
100509,4,3,O
100509,4,cm,O
100509,4,in,O
100509,4,craniocaudal,O
100509,4,dimension,O
100509,5,.,O
100509,5,Indirect,O
100509,5,evidence,O
100509,5,of,O
100509,5,right,O
100509,5,brachiocephalic,O
100509,5,vein,O
100509,5,occlusion,O
100509,5,",",O
100509,5,likely,O
100509,5,complete,O
100509,5,.,O
100509,5,Unchanged,O
100509,5,narrowing,O
100509,5,of,O
100509,5,right,O
100509,5,pulmonary,O
100509,5,artery,O
100509,5,.,O
100509,5,Splayed,O
100509,5,but,O
100509,5,patent,O
100509,5,aortic,O
100509,5,arch,O
100509,5,branches,O
100509,5,.,O
100509,5,2,O
100509,5,.,O
100509,5,Interval,O
100509,5,decrease,O
100509,5,in,O
100509,5,large,O
100509,5,right,O
100509,5,pleural,O
100509,5,effusion,O
100509,5,",",O
100509,5,with,O
100509,5,small,O
100509,5,anterior,O
100509,5,pneumothorax,O
100509,5,.,O
100509,5,Right,O
100509,5,chest,O
100509,5,tube,O
100509,5,terminating,O
100509,5,at,O
100509,5,apex,O
100509,5,.,O
100509,5,3,O
100509,5,.,O
100509,5,No,O
100509,5,interval,O
100509,5,change,O
100509,5,in,O
100509,5,large,O
100509,5,infiltrative,O
100509,5,hypoattenuating,O
100509,5,right,O
100509,5,hilar/mediastinal,O
100509,5,mass,O
100509,5,.,O
100509,5,4,O
100509,5,.,O
100509,5,No,O
100509,5,evidence,O
100509,5,of,O
100509,5,metastases,O
100509,5,in,O
100509,5,the,O
100509,5,abdomen,O
100509,5,or,O
100509,5,pelvis,O
100509,5,.,O
100509,5,Slightly,O
100509,5,bulky,O
100509,5,left,O
100509,5,adrenal,O
100509,5,gland,O
100509,5,without,O
100509,5,discrete,O
100509,5,nodule,O
100509,5,or,O
100509,5,mass,O
100509,5,.,O
100509,5,5,O
100509,5,.,O
100509,5,Anasarca,O
100509,5,and,O
100509,5,small,O
100509,5,amount,O
100509,5,of,O
100509,5,peritoneal,O
100509,5,fluid,O
100509,5,collecting,O
100509,5,in,O
100509,5,the,O
100509,5,pelvis,O
100509,5,",",O
100509,5,likely,O
100509,5,related,O
100509,5,to,O
100509,5,edema,O
100509,5,.,O
100509,5,6,O
100509,5,.,O
100509,5,Interval,O
100509,5,tracheal,O
100509,5,stenting,O
100509,5,with,O
100509,5,improved,O
100509,5,caliber,O
100509,5,of,O
100509,5,airway,O
100509,5,.,O
100509,5,.,O
100509,5,[,O
100509,5,**2172-8-27**,O
100509,5,],O
100509,5,ECHO,O
100509,5,:,O
100509,5,Compared,O
100509,5,with,O
100509,5,the,O
100509,5,prior,O
100509,5,study,O
100509,5,(,O
100509,5,images,O
100509,5,reviewed,O
100509,5,),O
100509,5,of,O
100509,5,[,O
100509,5,**2172-8-26**,O
100509,5,],O
100509,5,",",O
100509,5,the,O
100509,5,size,O
100509,5,of,O
100509,5,the,O
100509,5,pericardial,O
100509,5,effusion,O
100509,5,is,O
100509,5,unchanged,O
100509,5,with,O
100509,5,no,O
100509,5,signs,O
100509,5,of,O
100509,5,tamponade,O
100509,5,.,O
100509,5,The,O
100509,5,left,O
100509,5,ventricle,O
100509,5,seems,O
100509,5,to,O
100509,5,be,O
100509,5,underfilled,O
100509,5,.,O
100509,5,.,O
100509,5,[,O
100509,5,**8-28**,O
100509,5,],O
100509,5,CT,O
100509,5,Head,O
100509,5,:,O
100509,5,1,O
100509,5,.,O
100509,5,Within,O
100509,5,limits,O
100509,5,of,O
100509,5,this,O
100509,5,modality,O
100509,5,",",O
100509,5,no,O
100509,5,evidence,O
100509,5,of,O
100509,5,enhancing,O
100509,5,mass,O
100509,5,or,O
100509,5,edema,O
100509,5,to,O
100509,5,suggest,O
100509,5,metastatic,O
100509,5,disease,O
100509,5,.,O
100509,5,2,O
100509,5,.,O
100509,5,Status,O
100509,5,post,O
100509,5,bilateral,O
100509,5,frontal,O
100509,5,craniotomy,O
100509,5,and,O
100509,5,probable,O
100509,5,aneurysm,O
100509,5,clipping,O
100509,5,with,O
100509,5,encephalomalacic,O
100509,5,changes,O
100509,5,in,O
100509,5,the,O
100509,5,right,O
100509,5,frontotemporal,O
100509,5,and,O
100509,5,left,O
100509,5,temporal,O
100509,5,lobes,O
100509,5,.,O
100509,5,No,O
100509,5,evidence,O
100509,5,of,O
100509,5,acute,O
100509,5,hemorrhage,O
100509,5,or,O
100509,5,infarct,O
100509,5,.,O
100509,5,3,O
100509,5,.,O
100509,5,Probable,O
100509,5,chronic,O
100509,5,bifrontal,O
100509,5,subdural,O
100509,5,hygromas,O
100509,5,with,O
100509,5,minimal,O
100509,5,mass,O
100509,5,effect,O
100509,5,on,O
100509,5,the,O
100509,5,subjacent,O
100509,5,frontal,O
100509,5,gyri,O
100509,5,;,O
100509,5,these,O
100509,5,may,O
100509,5,relate,O
100509,5,to,O
100509,5,the,O
100509,5,extensive,O
100509,5,remote,O
100509,5,surgery,O
100509,5,.,O
100509,5,[,O
100509,5,**2172-9-2**,O
100509,5,],O
100509,5,CT,O
100509,5,Head,O
100509,5,(,O
100509,5,performed,O
100509,5,due,O
100509,5,to,O
100509,5,worsened,O
100509,5,mental,O
100509,5,status,O
100509,5,),O
100509,5,:,O
100509,5,1,O
100509,5,.,O
100509,5,Unchanged,O
100509,5,examination,O
100509,5,from,O
100509,5,recent,O
100509,5,exam,O
100509,5,of,O
100509,5,[,O
100509,5,**2172-8-28**,O
100509,5,],O
100509,5,.,O
100509,5,2,O
100509,5,.,O
100509,5,Status,O
100509,5,post,O
100509,5,bilateral,O
100509,5,frontal,O
100509,5,craniotomies,O
100509,5,with,O
100509,5,aneurysm,O
100509,5,clipping,O
100509,5,and,O
100509,5,encephalomalcia,O
100509,5,",",O
100509,5,as,O
100509,5,described,O
100509,5,above,O
100509,5,.,O
100509,5,No,O
100509,5,evidence,O
100509,5,of,O
100509,5,acute,O
100509,5,hemorrhage,O
100509,5,or,O
100509,5,infarct,O
100509,5,.,O
100509,5,.,O
100509,5,[,O
100509,5,**2172-9-3**,O
100509,5,],O
100509,5,Renal,O
100509,5,US,O
100509,5,:,O
100509,5,1,O
100509,5,.,O
100509,6,Mildly,O
100509,6,echogenic,O
100509,6,kidneys,O
100509,6,consistent,O
100509,6,with,O
100509,6,medical,O
100509,6,renal,O
100509,6,disease,O
100509,6,.,O
100509,6,There,O
100509,6,is,O
100509,6,no,O
100509,6,evidence,O
100509,6,of,O
100509,6,hydronephrosis,O
100509,6,",",O
100509,6,stone,O
100509,6,",",O
100509,6,or,O
100509,6,mass,O
100509,6,.,O
100509,6,2,O
100509,6,.,O
100509,6,The,O
100509,6,left,O
100509,6,kidney,O
100509,6,remains,O
100509,6,atrophic,O
100509,6,and,O
100509,6,lobulated,O
100509,6,",",O
100509,6,similar,O
100509,6,to,O
100509,6,[,O
100509,6,**2172-8-27**,O
100509,6,],O
100509,6,.,O
100509,6,.,O
100509,6,[,O
100509,6,**2172-9-4**,O
100509,6,],O
100509,6,CT,O
100509,6,Chest,O
100509,6,w/o,O
100509,6,contrast,O
100509,6,(,O
100509,6,to,O
100509,6,evaluate,O
100509,6,tumor,O
100509,6,s/p,O
100509,6,XRT,O
100509,6,and,O
100509,6,chemo,O
100509,6,for,O
100509,6,future,O
100509,6,XRT,O
100509,6,sessions,O
100509,6,),O
100509,6,:,O
100509,6,1,O
100509,6,.,O
100509,6,Right,O
100509,6,anterior,O
100509,6,pneumothorax,O
100509,6,has,O
100509,6,resolved,O
100509,6,.,O
100509,6,2,O
100509,6,.,O
100509,6,Mixed,O
100509,6,response,O
100509,6,of,O
100509,6,the,O
100509,6,tumor,O
100509,6,to,O
100509,6,radiotherapy,O
100509,6,with,O
100509,6,a,O
100509,6,decrease,O
100509,6,of,O
100509,6,the,O
100509,6,central,O
100509,6,component,O
100509,6,of,O
100509,6,the,O
100509,6,tumor,O
100509,6,and,O
100509,6,a,O
100509,6,mixed,O
100509,6,response,O
100509,6,of,O
100509,6,the,O
100509,6,peripheral,O
100509,6,tumor,O
100509,6,components,O
100509,6,:,O
100509,6,3,O
100509,6,.,O
100509,6,The,O
100509,6,peripheral,O
100509,6,consolidations,O
100509,6,in,O
100509,6,the,O
100509,6,right,O
100509,6,upper,O
100509,6,lobe,O
100509,6,have,O
100509,6,overall,O
100509,6,decreased,O
100509,6,in,O
100509,6,size,O
100509,6,",",O
100509,6,however,O
100509,6,",",O
100509,6,a,O
100509,6,new,O
100509,6,cavitary,O
100509,6,lesion,O
100509,6,has,O
100509,6,formed,O
100509,6,measuring,O
100509,6,11,O
100509,6,x,O
100509,6,19,O
100509,6,mm,O
100509,6,.,O
100509,6,4,O
100509,6,.,O
100509,6,The,O
100509,6,peripheral,O
100509,6,consolidations,O
100509,6,in,O
100509,6,the,O
100509,6,right,O
100509,6,lower,O
100509,6,lobe,O
100509,6,and,O
100509,6,left,O
100509,6,lower,O
100509,6,lobe,O
100509,6,have,O
100509,6,increased,O
100509,6,in,O
100509,6,size,O
100509,6,",",O
100509,6,number,O
100509,6,and,O
100509,6,density,O
100509,6,and,O
100509,6,may,O
100509,6,be,O
100509,6,part,O
100509,6,of,O
100509,6,post-,O
100509,6,obstructive,O
100509,6,",",O
100509,6,post-radiotherapy,O
100509,6,",",O
100509,6,post-infectious,O
100509,6,",",O
100509,6,or,O
100509,6,acute,O
100509,6,inflammatory,O
100509,6,changes,O
100509,6,.,O
100509,6,5,O
100509,6,.,O
100509,6,Lymphangio-carcinomatosis,O
100509,6,in,O
100509,6,the,O
100509,6,right,O
100509,6,upper,O
100509,6,lobe,O
100509,6,.,O
100509,6,6,O
100509,6,.,O
100509,6,There,O
100509,6,is,O
100509,6,new,O
100509,6,small,O
100509,6,right,O
100509,6,pleural,O
100509,6,effusion,O
100509,6,and,O
100509,6,increased,O
100509,6,moderate,O
100509,6,left,O
100509,6,pleural,O
100509,6,effusion,O
100509,6,.,O
100509,6,7,O
100509,6,.,O
100509,6,Left,O
100509,6,adrenal,O
100509,6,gland,O
100509,6,mass,O
100509,6,is,O
100509,6,only,O
100509,6,partially,O
100509,6,visualized,O
100509,6,in,O
100509,6,this,O
100509,6,study,O
100509,6,.,O
100509,6,.,O
100509,6,[,O
100509,6,**2172-9-3**,O
100509,6,],O
100509,6,EEG,O
100509,6,:,O
100509,6,Markedly,O
100509,6,abnormal,O
100509,6,portable,O
100509,6,EEG,O
100509,6,due,O
100509,6,to,O
100509,6,the,O
100509,6,very,O
100509,6,disorganized,O
100509,6,and,O
100509,6,slow,O
100509,6,background,O
100509,6,rhythms,O
100509,6,.,O
100509,6,This,O
100509,6,suggests,O
100509,6,a,O
100509,6,widespread,O
100509,6,and,O
100509,6,moderately,O
100509,6,severe,O
100509,6,encephalopathy,O
100509,6,in,O
100509,6,both,O
100509,6,cortical,O
100509,6,and,O
100509,6,subcortical,O
100509,6,structures,O
100509,6,.,O
100509,6,Medications,O
100509,6,",",O
100509,6,metabolic,O
100509,6,disturbances,O
100509,6,",",O
100509,6,and,O
100509,6,infection,O
100509,6,are,O
100509,6,among,O
100509,6,the,O
100509,6,most,O
100509,6,common,O
100509,6,causes,O
100509,6,.,O
100509,6,Although,O
100509,6,there,O
100509,6,were,O
100509,6,fleeting,O
100509,6,asymmetries,O
100509,6,",",O
100509,6,there,O
100509,6,was,O
100509,6,no,O
100509,6,reliable,O
100509,6,area,O
100509,6,of,O
100509,6,focal,O
100509,6,slowing,O
100509,6,.,O
100509,6,Encephalopathies,O
100509,6,may,O
100509,6,obscure,O
100509,6,focal,O
100509,6,findings,O
100509,6,.,O
100509,6,There,O
100509,6,are,O
100509,6,some,O
100509,6,sharp,O
100509,6,features,O
100509,6,",",O
100509,6,but,O
100509,6,no,O
100509,6,clearly,O
100509,6,epileptiform,O
100509,6,abnormalities,O
100509,6,and,O
100509,6,no,O
100509,6,electrographic,O
100509,6,seizures,O
100509,6,.,O
100509,6,.,O
100509,6,[,O
100509,6,**2172-9-5**,O
100509,6,],O
100509,6,LENI,O
100509,6,:,O
100509,6,no,O
100509,6,DVT,O
100509,6,.,O
100509,6,[,O
100509,7,**2172-9-5**,O
100509,7,],O
100509,7,ECHO,O
100509,7,:,O
100509,7,final,O
100509,7,read,O
100509,7,pending,O
100509,7,.,O
100509,7,Micro,O
100509,7,:,O
100509,7,[,O
100509,7,**2172-8-26**,O
100509,7,],O
100509,7,Pleural,O
100509,7,fluid,O
100509,7,:,O
100509,7,GRAM,O
100509,7,STAIN,O
100509,7,(,O
100509,7,Final,O
100509,7,[,O
100509,7,**2172-8-26**,O
100509,7,],O
100509,7,),O
100509,7,:,O
100509,7,3+,O
100509,7,(,O
100509,7,5-10,O
100509,7,per,O
100509,7,1000X,O
100509,7,FIELD,O
100509,7,),O
100509,7,:,O
100509,7,POLYMORPHONUCLEAR,O
100509,7,LEUKOCYTES,O
100509,7,.,O
100509,7,NO,O
100509,7,MICROORGANISMS,O
100509,7,SEEN,O
100509,7,.,O
100509,7,FLUID,O
100509,7,CULTURE,O
100509,7,(,O
100509,7,Final,O
100509,7,[,O
100509,7,**2172-8-29**,O
100509,7,],O
100509,7,),O
100509,7,:,O
100509,7,NO,O
100509,7,GROWTH,O
100509,7,.,O
100509,7,ANAEROBIC,O
100509,7,CULTURE,O
100509,7,(,O
100509,7,Final,O
100509,7,[,O
100509,7,**2172-9-1**,O
100509,7,],O
100509,7,),O
100509,7,:,O
100509,7,NO,O
100509,7,GROWTH,O
100509,7,.,O
100509,7,ACID,O
100509,7,FAST,O
100509,7,SMEAR,O
100509,7,(,O
100509,7,Final,O
100509,7,[,O
100509,7,**2172-8-27**,O
100509,7,],O
100509,7,),O
100509,7,:,O
100509,7,no,O
100509,7,AFB,O
100509,7,seen,O
100509,7,on,O
100509,7,direct,O
100509,7,smear,O
100509,7,ACID,O
100509,7,FAST,O
100509,7,CULTURE,O
100509,7,(,O
100509,7,Preliminary,O
100509,7,),O
100509,7,:,O
100509,7,PENDING,O
100509,7,Cytology,O
100509,7,:,O
100509,7,Atypical,O
100509,7,cells,O
100509,7,",",O
100509,7,non-specific,O
100509,7,findings,O
100509,7,.,O
100509,7,[,O
100509,7,**2172-9-4**,O
100509,7,],O
100509,7,BAL,O
100509,7,:,O
100509,7,GRAM,O
100509,7,STAIN,O
100509,7,(,O
100509,7,Final,O
100509,7,[,O
100509,7,**2172-9-4**,O
100509,7,],O
100509,7,),O
100509,7,:,O
100509,7,1+,O
100509,7,(,O
100509,7,<,O
100509,7,1,O
100509,7,per,O
100509,7,1000X,O
100509,7,FIELD,O
100509,7,),O
100509,7,:,O
100509,7,POLYMORPHONUCLEAR,O
100509,7,LEUKOCYTES,O
100509,7,.,O
100509,7,1+,O
100509,7,(,O
100509,7,<,O
100509,7,1,O
100509,7,per,O
100509,7,1000X,O
100509,7,FIELD,O
100509,7,),O
100509,7,:,O
100509,7,GRAM,O
100509,7,NEGATIVE,O
100509,7,ROD,O
100509,7,(,O
100509,7,S,O
100509,7,),O
100509,7,.,O
100509,7,1+,O
100509,7,(,O
100509,7,<,O
100509,7,1,O
100509,7,per,O
100509,7,1000X,O
100509,7,FIELD,O
100509,7,),O
100509,7,:,O
100509,7,BUDDING,O
100509,7,YEAST,O
100509,7,WITH,O
100509,7,PSEUDOHYPHAE,O
100509,7,.,O
100509,7,RESPIRATORY,O
100509,7,CULTURE,O
100509,7,(,O
100509,7,Preliminary,O
100509,7,),O
100509,7,:,O
100509,7,FUNGAL,O
100509,7,CULTURE,O
100509,7,(,O
100509,7,Preliminary,O
100509,7,),O
100509,7,:,O
100509,7,.,O
100509,7,[,O
100509,7,**2172-9-3**,O
100509,7,],O
100509,7,CSF,O
100509,7,:,O
100509,7,GRAM,O
100509,7,STAIN,O
100509,7,(,O
100509,7,Final,O
100509,7,[,O
100509,7,**2172-9-3**,O
100509,7,],O
100509,7,),O
100509,7,:,O
100509,7,NO,O
100509,7,POLYMORPHONUCLEAR,O
100509,7,LEUKOCYTES,O
100509,7,SEEN,O
100509,7,.,O
100509,7,NO,O
100509,7,MICROORGANISMS,O
100509,7,SEEN,O
100509,7,.,O
100509,7,FLUID,O
100509,7,CULTURE,O
100509,7,(,O
100509,7,Preliminary,O
100509,7,),O
100509,7,:,O
100509,7,NO,O
100509,7,GROWTH,O
100509,7,.,O
100509,7,Cytology,O
100509,7,:,O
100509,7,no,O
100509,7,malignant,O
100509,7,cells,O
100509,7,.,O
100509,7,C.,O
100509,7,diff,O
100509,7,negative,O
100509,7,.,O
100509,7,[,O
100509,7,**8-30**,O
100509,7,],O
100509,7,Blood,O
100509,7,Cx,O
100509,7,?,O
100509,7,?,O
100509,7,?,O
100509,7,?,O
100509,7,?,O
100509,7,?,O
100509,7,NGTD,O
100509,7,[,O
100509,7,**9-5**,O
100509,7,],O
100509,7,Blooc,O
100509,7,cx,O
100509,7,-,O
100509,7,pending,O
100509,7,.,O
100509,7,Bronchoscopy,O
100509,7,[,O
100509,7,**2172-9-4**,O
100509,7,],O
100509,7,:,O
100509,7,lots,O
100509,7,of,O
100509,7,necrotic,O
100509,7,tissue,O
100509,7,noted,O
100509,7,",",O
100509,7,ETT,O
100509,7,tube,O
100509,7,dislodged,O
100509,7,between,O
100509,7,stent,O
100509,7,and,O
100509,7,tracheal,O
100509,7,wall,O
100509,7,",",O
100509,7,repositioned,O
100509,7,during,O
100509,7,bronch,O
100509,7,.,O
100509,7,Brief,O
100509,7,Hospital,O
100509,7,Course,O
100509,7,:,O
100509,7,[,O
100509,7,**Hospital,O
100509,7,Unit,O
100509,7,Name,O
100509,7,153**,O
100509,7,],O
100509,7,Course,O
100509,7,[,O
100509,7,**Date,O
100509,7,range,O
100509,7,(,O
100509,7,3,O
100509,7,),O
100509,7,84902**,O
100509,7,],O
100509,7,58F,O
100509,7,with,O
100509,7,likely,O
100509,7,small,O
100509,7,cell,O
100509,7,carcinoma,O
100509,7,complicated,O
100509,7,by,O
100509,7,SVC,O
100509,7,syndrome,O
100509,7,",",O
100509,7,airway,O
100509,7,compromise,O
100509,7,requiring,O
100509,7,Y-stent,O
100509,7,",",O
100509,7,pericardial,O
100509,7,effusion,O
100509,7,",",O
100509,7,resolved,O
100509,7,pleural,O
100509,7,effusion,O
100509,7,and,O
100509,7,pneumothorax,O
100509,7,",",O
100509,7,and,O
100509,7,electrolytes,O
100509,7,disturbances,O
100509,7,admitted,O
100509,7,to,O
100509,8,[,O
100509,8,**Hospital,O
100509,8,Unit,O
100509,8,Name,O
100509,8,153**,O
100509,8,],O
100509,8,for,O
100509,8,radiation,O
100509,8,decompression,O
100509,8,therapy,O
100509,8,and,O
100509,8,chemotherapy,B-Drug
100509,8,.,O
100509,8,Pt,O
100509,8,developed,O
100509,8,respiratory,O
100509,8,failure,O
100509,8,and,O
100509,8,renal,O
100509,8,failure,O
100509,8,.,O
100509,8,.,O
100509,8,#,O
100509,8,.,O
100509,8,Hypoxic,O
100509,8,respiratory,O
100509,8,failure,O
100509,8,:,O
100509,8,Pt,O
100509,8,was,O
100509,8,initially,O
100509,8,transferred,O
100509,8,from,O
100509,8,SICU,O
100509,8,to,O
100509,8,[,O
100509,8,**Hospital,O
100509,8,Unit,O
100509,8,Name,O
100509,8,153**,O
100509,8,],O
100509,8,on,O
100509,8,CPAP/PS,O
100509,8,.,O
100509,8,She,O
100509,8,developed,O
100509,8,increasing,O
100509,8,respiratory,O
100509,8,failure,O
100509,8,and,O
100509,8,was,O
100509,8,changed,O
100509,8,to,O
100509,8,AC,O
100509,8,mode,O
100509,8,.,O
100509,8,In,O
100509,8,the,O
100509,8,[,O
100509,8,**Hospital,O
100509,8,Unit,O
100509,8,Name,O
100509,8,153**,O
100509,8,],O
100509,8,",",O
100509,8,she,O
100509,8,underwent,O
100509,8,XRT,O
100509,8,x2,O
100509,8,and,O
100509,8,then,O
100509,8,chemotherapy,B-Drug
100509,8,for,O
100509,8,3,O
100509,8,days,O
100509,8,.,O
100509,8,Increased,O
100509,8,hypoxia,O
100509,8,may,O
100509,8,have,O
100509,8,been,O
100509,8,due,O
100509,8,to,O
100509,8,pneumothorax,O
100509,8,",",O
100509,8,which,O
100509,8,resolved,O
100509,8,",",O
100509,8,pleural,O
100509,8,effusions,O
100509,8,",",O
100509,8,atelectasis,O
100509,8,",",O
100509,8,possible,O
100509,8,VAP,O
100509,8,",",O
100509,8,tumor,O
100509,8,compression,O
100509,8,.,O
100509,8,During,O
100509,8,hypoxic,O
100509,8,episodes,O
100509,8,",",O
100509,8,pt,O
100509,8,underwent,O
100509,8,bronchoscopy,O
100509,8,twice,O
100509,8,",",O
100509,8,both,O
100509,8,times,O
100509,8,of,O
100509,8,which,O
100509,8,demonstrated,O
100509,8,the,O
100509,8,ETT,O
100509,8,lodged,O
100509,8,between,O
100509,8,tracheal,O
100509,8,wall,O
100509,8,and,O
100509,8,stent,O
100509,8,.,O
100509,8,Pt,O
100509,8,'s,O
100509,8,saturation,O
100509,8,improved,O
100509,8,with,O
100509,8,repositioning,O
100509,8,.,O
100509,8,Respiratory,O
100509,8,status,O
100509,8,also,O
100509,8,complicated,O
100509,8,by,O
100509,8,possible,O
100509,8,underlying,O
100509,8,COPD,O
100509,8,given,O
100509,8,smoking,O
100509,8,history,O
100509,8,with,O
100509,8,possible,O
100509,8,air,O
100509,8,stacking/trapping,O
100509,8,.,O
100509,8,Pt,O
100509,8,was,O
100509,8,started,O
100509,8,on,O
100509,8,vancomycin,B-Drug
100509,8,",",O
100509,8,cefepime,B-Drug
100509,8,and,O
100509,8,ciprofloxacin,B-Drug
100509,8,(,O
100509,8,started,O
100509,8,[,O
100509,8,**2172-8-31**,O
100509,8,],O
100509,8,for,O
100509,8,8,O
100509,8,day,O
100509,8,course,O
100509,8,),O
100509,8,for,O
100509,8,VAP,B-Reason
100509,8,.,O
100509,8,Vanco,B-Drug
100509,8,was,O
100509,8,later,O
100509,8,held,O
100509,8,as,O
100509,8,the,O
100509,8,level,O
100509,8,was,O
100509,8,elevated,O
100509,8,in,O
100509,8,the,O
100509,8,setting,O
100509,8,of,O
100509,8,renal,O
100509,8,failure,O
100509,8,.,O
100509,8,Patient's,O
100509,8,family,O
100509,8,decided,O
100509,8,to,O
100509,8,persue,O
100509,8,comfort,O
100509,8,only,O
100509,8,care,O
100509,8,on,O
100509,8,[,O
100509,8,**2172-9-6**,O
100509,8,],O
100509,8,",",O
100509,8,and,O
100509,8,she,O
100509,8,was,O
100509,8,terminally,O
100509,8,extubated,O
100509,8,.,O
100509,8,Patient,O
100509,8,expired,O
100509,8,15,O
100509,8,minutes,O
100509,8,later,O
100509,8,from,O
100509,8,respiratory,O
100509,8,failure,O
100509,8,and,O
100509,8,asystole,O
100509,8,secondary,O
100509,8,to,O
100509,8,lung,O
100509,8,cancer,O
100509,8,.,O
100509,8,.,O
100509,8,#,O
100509,8,Altered,O
100509,8,Mental,O
100509,8,Status,O
100509,8,:,O
100509,8,Pt,O
100509,8,had,O
100509,8,decline,O
100509,8,in,O
100509,8,mental,O
100509,8,status,O
100509,8,over,O
100509,8,time,O
100509,8,.,O
100509,8,She,O
100509,8,initially,O
100509,8,withdrew,O
100509,8,from,O
100509,8,noxious,O
100509,8,stimuli,O
100509,8,but,O
100509,8,later,O
100509,8,was,O
100509,8,less,O
100509,8,responsive,O
100509,8,.,O
100509,8,AMS,O
100509,8,continued,O
100509,8,despite,O
100509,8,sedation,O
100509,8,being,O
100509,8,off,O
100509,8,.,O
100509,8,AMS,O
100509,8,most,O
100509,8,likely,O
100509,8,due,O
100509,8,to,O
100509,8,toxic,O
100509,8,metabolic,O
100509,8,syndrome,O
100509,8,in,O
100509,8,setting,O
100509,8,of,O
100509,8,uremia,O
100509,8,and,O
100509,8,multi-system,O
100509,8,organ,O
100509,8,failure,O
100509,8,.,O
100509,8,Differential,O
100509,8,also,O
100509,8,included,O
100509,8,seizure,O
100509,8,(,O
100509,8,given,O
100509,8,hx,O
100509,8,of,O
100509,8,cerebral,O
100509,8,aneurysm,O
100509,8,repair,O
100509,8,",",O
100509,8,on,O
100509,8,anti-epileptics,O
100509,8,presumably,O
100509,8,prophylactically,O
100509,8,),O
100509,8,although,O
100509,8,EEG,O
100509,8,did,O
100509,8,not,O
100509,8,demonstrate,O
100509,8,focal,O
100509,8,abnormalities,O
100509,8,.,O
100509,8,LP,O
100509,8,did,O
100509,8,not,O
100509,8,demonstrate,O
100509,8,infection,O
100509,8,or,O
100509,8,spread,O
100509,9,of,O
100509,9,malignancy,O
100509,9,.,O
100509,9,CT,O
100509,9,head,O
100509,9,[,O
100509,9,**2172-9-2**,O
100509,9,],O
100509,9,negative,O
100509,9,for,O
100509,9,acute,O
100509,9,process,O
100509,9,.,O
100509,9,.,O
100509,9,#,O
100509,9,.,O
100509,9,Small,O
100509,9,cell,O
100509,9,lung,O
100509,9,carcinoma,O
100509,9,:,O
100509,9,per,O
100509,9,pathology,O
100509,9,",",O
100509,9,the,O
100509,9,tumor,O
100509,9,probably,O
100509,9,fits,O
100509,9,into,O
100509,9,the,O
100509,9,spectrum,O
100509,9,of,O
100509,9,a,O
100509,9,small,O
100509,9,cell,O
100509,9,carcinoma,O
100509,9,of,O
100509,9,lung,O
100509,9,.,O
100509,9,Given,O
100509,9,associated,O
100509,9,SVC,O
100509,9,syndrome,O
100509,9,",",O
100509,9,prognosis,O
100509,9,poor,O
100509,9,.,O
100509,9,CT,O
100509,9,head/,O
100509,9,[,O
100509,9,**Last,O
100509,9,Name,O
100509,9,(,O
100509,9,un,O
100509,9,),O
100509,9,103**,O
100509,9,],O
100509,9,/pelvis,O
100509,9,negative,O
100509,9,for,O
100509,9,metastases,O
100509,9,.,O
100509,9,Pt,O
100509,9,underwent,O
100509,9,3,O
100509,9,days,O
100509,9,of,O
100509,9,chemotherapy,B-Drug
100509,9,and,O
100509,9,2,O
100509,9,sessions,O
100509,9,of,O
100509,9,XRT,O
100509,9,.,O
100509,9,Initially,O
100509,9,",",O
100509,9,XRT,O
100509,9,was,O
100509,9,clinical,O
100509,9,emergency,O
100509,9,-,O
100509,9,normal,O
100509,9,and,O
100509,9,pathologic,O
100509,9,tissue,O
100509,9,was,O
100509,9,likely,O
100509,9,treated,O
100509,9,;,O
100509,9,necrotic,O
100509,9,tissue,O
100509,9,noted,O
100509,9,on,O
100509,9,bronchoscopy,O
100509,9,[,O
100509,9,**2172-9-4**,O
100509,9,],O
100509,9,.,O
100509,9,Pt,O
100509,9,was,O
100509,9,to,O
100509,9,undergo,O
100509,9,formal,O
100509,9,tissue,O
100509,9,planning,O
100509,9,session,O
100509,9,on,O
100509,9,[,O
100509,9,**2172-9-8**,O
100509,9,],O
100509,9,to,O
100509,9,better,O
100509,9,delineate,O
100509,9,area,O
100509,9,of,O
100509,9,radiation,O
100509,9,however,O
100509,9,family,O
100509,9,decided,O
100509,9,to,O
100509,9,persue,O
100509,9,comfort,O
100509,9,only,O
100509,9,care,O
100509,9,on,O
100509,9,[,O
100509,9,**2172-9-6**,O
100509,9,],O
100509,9,.,O
100509,9,.,O
100509,9,#,O
100509,9,Acute,B-ADE
100509,9,Renal,I-ADE
100509,9,failure,I-ADE
100509,9,:,O
100509,9,In,O
100509,9,setting,O
100509,9,of,O
100509,9,chemo,B-Drug
100509,9,with,O
100509,9,carboplatin,B-Drug
100509,9,.,O
100509,9,Urine,O
100509,9,casts,O
100509,9,consistent,O
100509,9,with,O
100509,9,ATN,O
100509,9,.,O
100509,9,Uric,O
100509,9,acid,O
100509,9,and,O
100509,9,electrolytes,O
100509,9,elevated,O
100509,9,4-5d,O
100509,9,post,O
100509,9,chemotherapy,B-Drug
100509,9,concerning,O
100509,9,for,O
100509,9,tumor,B-ADE
100509,9,lysis,I-ADE
100509,9,syndrome,I-ADE
100509,9,.,O
100509,9,The,O
100509,9,next,O
100509,9,therapeutic,O
100509,9,step,O
100509,9,was,O
100509,9,dialysis,O
100509,9,as,O
100509,9,patient,O
100509,9,became,O
100509,9,oliguric,O
100509,9,despite,O
100509,9,volume,O
100509,9,overload,O
100509,9,but,O
100509,9,the,O
100509,9,family,O
100509,9,wished,O
100509,9,for,O
100509,9,comfort,O
100509,9,only,O
100509,9,care,O
100509,9,given,O
100509,9,dismal,O
100509,9,prognosis,O
100509,9,of,O
100509,9,her,O
100509,9,lung,O
100509,9,cancer,O
100509,9,.,O
100509,9,.,O
100509,9,#,O
100509,9,.,O
100509,9,Metabolic,O
100509,9,acidosis,O
100509,9,:,O
100509,9,Originally,O
100509,9,thought,O
100509,9,to,O
100509,9,be,O
100509,9,non-gap,O
100509,9,metabolic,O
100509,9,acidosis,O
100509,9,due,O
100509,9,to,O
100509,9,hypoaldosteronism,O
100509,9,and,O
100509,9,type,O
100509,9,IV,O
100509,9,RTA,O
100509,9,.,O
100509,9,With,O
100509,9,low,O
100509,9,albumin,O
100509,9,",",O
100509,9,however,O
100509,9,",",O
100509,9,this,O
100509,9,is,O
100509,9,a,O
100509,9,gap,O
100509,9,metabolic,O
100509,9,acidosis,O
100509,9,",",O
100509,9,most,O
100509,9,likely,O
100509,9,due,O
100509,9,to,O
100509,9,uremia,O
100509,9,.,O
100509,9,Unable,O
100509,9,to,O
100509,9,increase,O
100509,9,RR,O
100509,9,to,O
100509,9,compensate,O
100509,9,due,O
100509,9,to,O
100509,9,concern,O
100509,9,for,O
100509,9,auto-peeping,O
100509,9,in,O
100509,9,setting,O
100509,9,of,O
100509,9,possible,O
100509,9,COPD,O
100509,9,.,O
100509,9,Goal,O
100509,9,pH,O
100509,9,is,O
100509,9,7.3-7.35,O
100509,9,.,O
100509,9,On,O
100509,9,[,O
100509,9,**2172-9-5**,O
100509,9,],O
100509,9,",",O
100509,9,pt,O
100509,9,'s,O
100509,9,acidosis,O
100509,9,worsened,O
100509,9,with,O
100509,9,pH,O
100509,9,7.16-7.18,O
100509,9,.,O
100509,9,Despite,O
100509,9,adjusting,O
100509,9,ETT,O
100509,9,placement,O
100509,9,and,O
100509,9,decreasing,O
100509,9,RR,O
100509,9,to,O
100509,9,reduce,O
100509,9,auto-peep,O
100509,9,",",O
100509,9,pt,O
100509,9,'s,O
100509,9,acidosis,O
100509,9,worsened,O
100509,9,.,O
100509,9,Bicarbonate,O
100509,9,was,O
100509,9,given,O
100509,9,.,O
100509,9,.,O
100509,9,#,O
100509,9,Tachycardia/Hypotension,O
100509,9,?,O
100509,9,?,O
100509,9,?,O
100509,9,?,O
100509,9,?,O
100509,9,?,O
100509,9,Pt,O
100509,9,with,O
100509,9,tachycardia,O
100509,9,to,O
100509,9,140s,O
100509,10,and,O
100509,10,episodes,O
100509,10,of,O
100509,10,hypotension,O
100509,10,to,O
100509,10,SBP,O
100509,10,low,O
100509,10,80s,O
100509,10,.,O
100509,10,Pt,O
100509,10,with,O
100509,10,new,O
100509,10,A-fib,O
100509,10,on,O
100509,10,telemetry,O
100509,10,and,O
100509,10,EKG,O
100509,10,.,O
100509,10,DDx,O
100509,10,includes,O
100509,10,possible,O
100509,10,enlarging,O
100509,10,pericardial,O
100509,10,effusion/tamponade,O
100509,10,but,O
100509,10,pulsus,O
100509,10,paradoxus,O
100509,10,was,O
100509,10,normal,O
100509,10,and,O
100509,10,ECHO,O
100509,10,[,O
100509,10,**2172-9-5**,O
100509,10,],O
100509,10,was,O
100509,10,unchanged,O
100509,10,from,O
100509,10,prior,O
100509,10,.,O
100509,10,No,O
100509,10,pneumothorax,O
100509,10,seen,O
100509,10,on,O
100509,10,CXR,O
100509,10,.,O
100509,10,Unable,O
100509,10,to,O
100509,10,assess,O
100509,10,for,O
100509,10,PE,O
100509,10,by,O
100509,10,CTA,O
100509,10,as,O
100509,10,pt,O
100509,10,in,O
100509,10,renal,O
100509,10,failure,O
100509,10,and,O
100509,10,VQ,O
100509,10,would,O
100509,10,not,O
100509,10,be,O
100509,10,helpful,O
100509,10,in,O
100509,10,setting,O
100509,10,of,O
100509,10,other,O
100509,10,lung,O
100509,10,pathology,O
100509,10,.,O
100509,10,LENI's,O
100509,10,negative,O
100509,10,for,O
100509,10,DVT,O
100509,10,.,O
100509,10,PE,O
100509,10,likely,O
100509,10,given,O
100509,10,malignancy,O
100509,10,and,O
100509,10,prolonged,O
100509,10,bed,O
100509,10,rest,O
100509,10,but,O
100509,10,unable,O
100509,10,to,O
100509,10,do,O
100509,10,CTA,O
100509,10,given,O
100509,10,renal,O
100509,10,failure,O
100509,10,and,O
100509,10,VQ,O
100509,10,scan,O
100509,10,not,O
100509,10,helpful,O
100509,10,in,O
100509,10,setting,O
100509,10,of,O
100509,10,lung,O
100509,10,changes,O
100509,10,.,O
100509,10,Even,O
100509,10,if,O
100509,10,it,O
100509,10,had,O
100509,10,been,O
100509,10,positive,O
100509,10,",",O
100509,10,heme/onc,O
100509,10,recommended,O
100509,10,against,O
100509,10,anti-coagulation,B-Drug
100509,10,in,O
100509,10,setting,O
100509,10,of,O
100509,10,possible,O
100509,10,tumor,O
100509,10,necrosis/hemorrhage,O
100509,10,.,O
100509,10,Pt,O
100509,10,remained,O
100509,10,tachycardic,O
100509,10,to,O
100509,10,130s,O
100509,10,despite,O
100509,10,numerous,O
100509,10,fluid,B-Drug
100509,10,boluses,O
100509,10,.,O
100509,10,.,O
100509,10,#,O
100509,10,.,O
100509,10,Electrolyte,O
100509,10,disturbances,O
100509,10,:,O
100509,10,Pt,O
100509,10,developed,O
100509,10,hypernatremia,O
100509,10,on,O
100509,10,[,O
100509,10,**2172-9-4**,O
100509,10,],O
100509,10,most,O
100509,10,likley,O
100509,10,due,O
100509,10,to,O
100509,10,dehydration,B-Reason
100509,10,with,I-Reason
100509,10,free,I-Reason
100509,10,water,I-Reason
100509,10,deficit,I-Reason
100509,10,of,O
100509,10,1.4L,O
100509,10,",",O
100509,10,started,O
100509,10,on,O
100509,10,D5W,B-Drug
100509,10,.,O
100509,10,Pt,O
100509,10,had,O
100509,10,hyponatremia,O
100509,10,and,O
100509,10,hyperkalemia,O
100509,10,on,O
100509,10,admission,O
100509,10,",",O
100509,10,both,O
100509,10,resolved,O
100509,10,.,O
100509,10,Unclear,O
100509,10,etiology,O
100509,10,of,O
100509,10,electrolyte,O
100509,10,disturbances,O
100509,10,on,O
100509,10,admission-,O
100509,10,hyponatremia,O
100509,10,thought,O
100509,10,to,O
100509,10,be,O
100509,10,secondary,O
100509,10,to,O
100509,10,possible,O
100509,10,adrenal,O
100509,10,insufficency,O
100509,10,(,O
100509,10,now,O
100509,10,discarded,O
100509,10,),O
100509,10,or,O
100509,10,possibly,O
100509,10,SIADH,O
100509,10,.,O
100509,10,Low,O
100509,10,UNa,O
100509,10,does,O
100509,10,not,O
100509,10,exclude,O
100509,10,SIADH,O
100509,10,;,O
100509,10,renal,O
100509,10,recommended,O
100509,10,rechecking,O
100509,10,urine,O
100509,10,lytes,O
100509,10,with,O
100509,10,saline,O
100509,10,load,O
100509,10,",",O
100509,10,whcih,O
100509,10,was,O
100509,10,not,O
100509,10,done,O
100509,10,in,O
100509,10,setting,O
100509,10,of,O
100509,10,pt,O
100509,10,?,O
100509,10,?,O
100509,10,?,O
100509,10,?,O
100509,10,?,O
100509,10,?,O
100509,10,s,O
100509,10,other,O
100509,10,medical,O
100509,10,issues,O
100509,10,.,O
100509,10,Hyperkalemia,O
100509,10,originally,O
100509,10,attributed,O
100509,10,to,O
100509,10,hypoaldosteronism,O
100509,10,and,O
100509,10,Type,O
100509,10,IV,O
100509,10,RTA,O
100509,10,",",O
100509,10,but,O
100509,10,unlikely,O
100509,10,per,O
100509,10,endocrine,O
100509,10,because,O
100509,10,of,O
100509,10,low,O
100509,10,urine,O
100509,10,sodium,O
100509,10,.,O
100509,10,.,O
100509,10,#,O
100509,10,.,O
100509,10,SVC,O
100509,10,syndrome,O
100509,10,:,O
100509,10,Incomplete,O
100509,10,occlusion,O
100509,10,of,O
100509,10,SVC,O
100509,10,;,O
100509,10,near,O
100509,10,complete,O
100509,10,occlusion,O
100509,10,of,O
100509,10,brachiocephalic,O
100509,10,veins,O
100509,10,.,O
100509,10,Clinically,O
100509,10,identified,O
100509,10,by,O
100509,10,upper,O
100509,10,extremity,O
100509,10,and,O
100509,10,facial,O
100509,10,swelling/plethora,O
100509,10,and,O
100509,10,mottled,O
100509,10,skin,O
100509,10,.,O
100509,10,Also,O
100509,10,with,O
100509,10,scleral,O
100509,10,edema,O
100509,10,.,O
100509,10,Unable,O
100509,10,to,O
100509,10,assess,O
100509,10,jugular,O
100509,10,venous,O
100509,10,distension,O
100509,10,given,O
100509,10,considerable,O
100509,10,swelling,O
100509,10,.,O
100509,10,Seen,O
100509,10,in,O
100509,10,appoximately,O
100509,10,10,O
100509,10,%,O
100509,10,cases,O
100509,11,of,O
100509,11,SSLC,O
100509,11,.,O
100509,11,Improved,O
100509,11,edema,O
100509,11,on,O
100509,11,exam,O
100509,11,compared,O
100509,11,to,O
100509,11,admission,O
100509,11,.,O
100509,11,SVC,O
100509,11,syndrome,O
100509,11,occurred,O
100509,11,after,O
100509,11,Y-stent,O
100509,11,placed,O
100509,11,.,O
100509,11,Possible,O
100509,11,that,O
100509,11,tumor,O
100509,11,pushing,O
100509,11,into,O
100509,11,trachea,O
100509,11,shifted,O
100509,11,to,O
100509,11,compress,O
100509,11,SVC,O
100509,11,after,O
100509,11,stent,O
100509,11,placement,O
100509,11,.,O
100509,11,She,O
100509,11,underwent,O
100509,11,radiation,O
100509,11,therapy,O
100509,11,and,O
100509,11,chemotherapy,B-Drug
100509,11,for,O
100509,11,decompression,B-Reason
100509,11,.,O
100509,11,.,O
100509,11,#,O
100509,11,.,O
100509,11,Pleural,O
100509,11,effusion,O
100509,11,:,O
100509,11,s/p,O
100509,11,right,O
100509,11,pigtail,O
100509,11,catheter,O
100509,11,placement,O
100509,11,[,O
100509,11,**2172-8-25**,O
100509,11,],O
100509,11,",",O
100509,11,removed,O
100509,11,[,O
100509,11,**2172-8-31**,O
100509,11,],O
100509,11,.,O
100509,11,LDH,O
100509,11,effusion/serum,O
100509,11,0.68,O
100509,11,(,O
100509,11,exudate,O
100509,11,by,O
100509,11,Light,O
100509,11,?,O
100509,11,?,O
100509,11,?,O
100509,11,?,O
100509,11,?,O
100509,11,?,O
100509,11,s,O
100509,11,criteria,O
100509,11,),O
100509,11,.,O
100509,11,Greatest,O
100509,11,concern,O
100509,11,for,O
100509,11,malignant,O
100509,11,effusion,O
100509,11,however,O
100509,11,cytology,O
100509,11,was,O
100509,11,nonspecific,O
100509,11,.,O
100509,11,Cultures,O
100509,11,of,O
100509,11,fluid,O
100509,11,all,O
100509,11,preliminary,O
100509,11,negative,O
100509,11,.,O
100509,11,.,O
100509,11,#,O
100509,11,.,O
100509,11,Pneumothorax,O
100509,11,:,O
100509,11,Developed,O
100509,11,pneumothorax,O
100509,11,in,O
100509,11,setting,O
100509,11,of,O
100509,11,re-intubation,O
100509,11,that,O
100509,11,resolved,O
100509,11,after,O
100509,11,chest,O
100509,11,tube,O
100509,11,placement,O
100509,11,.,O
100509,11,.,O
100509,11,#,O
100509,11,.,O
100509,11,Pericardial,O
100509,11,effusion,O
100509,11,:,O
100509,11,Suspected,O
100509,11,by,O
100509,11,cardiology,O
100509,11,to,O
100509,11,be,O
100509,11,malignant,O
100509,11,effusion,O
100509,11,.,O
100509,11,Felt,O
100509,11,not,O
100509,11,to,O
100509,11,be,O
100509,11,large,O
100509,11,enough,O
100509,11,for,O
100509,11,percutaneous,O
100509,11,drainage,O
100509,11,.,O
100509,11,EKG,O
100509,11,without,O
100509,11,signs,O
100509,11,of,O
100509,11,electrical,O
100509,11,alternans,O
100509,11,but,O
100509,11,does,O
100509,11,have,O
100509,11,low,O
100509,11,voltages,O
100509,11,.,O
100509,11,Repeat,O
100509,11,ECHO,O
100509,11,done,O
100509,11,[,O
100509,11,**2172-9-5**,O
100509,11,],O
100509,11,in,O
100509,11,setting,O
100509,11,of,O
100509,11,hypotension,O
100509,11,demonstrated,O
100509,11,no,O
100509,11,change,O
100509,11,in,O
100509,11,pericardial,O
100509,11,effusion,O
100509,11,.,O
100509,11,.,O
100509,11,#,O
100509,11,Sinus,O
100509,11,Pause,O
100509,11,on,O
100509,11,telemetry,O
100509,11,:,O
100509,11,Pt,O
100509,11,had,O
100509,11,episodes,O
100509,11,of,O
100509,11,sinus,O
100509,11,pauses,O
100509,11,on,O
100509,11,tele,O
100509,11,night,O
100509,11,of,O
100509,11,[,O
100509,11,**8-30**,O
100509,11,],O
100509,11,with,O
100509,11,turning,O
100509,11,to,O
100509,11,right,O
100509,11,side,O
100509,11,.,O
100509,11,Occurred,O
100509,11,again,O
100509,11,[,O
100509,11,**2172-9-4**,O
100509,11,],O
100509,11,again,O
100509,11,with,O
100509,11,re-positioning,O
100509,11,.,O
100509,11,Metoprolol,B-Drug
100509,11,was,O
100509,11,held,O
100509,11,and,O
100509,11,glucagon,B-Drug
100509,11,given,O
100509,11,in,O
100509,11,case,O
100509,11,this,O
100509,11,was,O
100509,11,due,O
100509,11,to,O
100509,11,beta,B-ADE
100509,11,blocker,I-ADE
100509,11,toxicity,I-ADE
100509,11,",",O
100509,11,but,O
100509,11,pauses,O
100509,11,decreased,O
100509,11,in,O
100509,11,frequency,O
100509,11,and,O
100509,11,duration,O
100509,11,on,O
100509,11,their,O
100509,11,own,O
100509,11,without,O
100509,11,intervention,O
100509,11,.,O
100509,11,Cardiology,O
100509,11,consulted,O
100509,11,who,O
100509,11,felt,O
100509,11,it,O
100509,11,was,O
100509,11,vagally,O
100509,11,mediated,O
100509,11,.,O
100509,11,[,O
100509,11,**Month,O
100509,11,(,O
100509,11,only,O
100509,11,),O
100509,11,116**,O
100509,11,],O
100509,11,have,O
100509,11,been,O
100509,11,due,O
100509,11,to,O
100509,11,ETT,O
100509,11,tube,O
100509,11,displacement,O
100509,11,pressing,O
100509,11,on,O
100509,11,carotid,O
100509,11,when,O
100509,11,pt,O
100509,11,was,O
100509,11,turned,O
100509,11,.,O
100509,11,.,O
100509,11,#,O
100509,11,Leukopenia,B-ADE
100509,11,/,O
100509,11,thrombocytopenia,B-ADE
100509,11,?,O
100509,11,?,O
100509,11,?,O
100509,11,?,O
100509,11,?,O
100509,11,?,O
100509,11,Most,O
100509,11,likely,O
100509,11,due,O
100509,11,to,O
100509,11,chemotherapy,B-Drug
100509,11,and,O
100509,11,no,O
100509,11,improvement,O
100509,11,in,O
100509,11,counts,O
100509,11,on,O
100509,11,neupogen,B-Drug
100509,11,.,O
100509,11,She,O
100509,11,was,O
100509,11,repeatedly,O
100509,11,pan-cultured,O
100509,11,with,O
100509,11,negative,O
100509,11,results,O
100509,11,.,O
100509,11,.,O
100509,11,#,O
100509,11,.,O
100509,11,Anemia,O
100509,11,:,O
100509,11,Normocytic,O
100509,11,and,O
100509,12,likely,O
100509,12,due,O
100509,12,to,O
100509,12,anemia,O
100509,12,of,O
100509,12,chronic,O
100509,12,disease,O
100509,12,given,O
100509,12,malignancy,O
100509,12,.,O
100509,12,Hemolysis,O
100509,12,labs,O
100509,12,were,O
100509,12,negative,O
100509,12,.,O
100509,12,.,O
100509,12,#,O
100509,12,s/p,O
100509,12,cerebral,O
100509,12,aneurysm,O
100509,12,repair,O
100509,12,:,O
100509,12,History,O
100509,12,of,O
100509,12,cerebral,O
100509,12,aneurysm,O
100509,12,repair,O
100509,12,with,O
100509,12,a,O
100509,12,number,O
100509,12,of,O
100509,12,chronic,O
100509,12,changes,O
100509,12,on,O
100509,12,head,O
100509,12,CT,O
100509,12,.,O
100509,12,Her,O
100509,12,antiepileptic,B-Drug
100509,12,medications,I-Drug
100509,12,were,O
100509,12,continued,O
100509,12,.,O
100509,12,Medications,O
100509,12,on,O
100509,12,Admission,O
100509,12,:,O
100509,12,Home,O
100509,12,medications,O
100509,12,:,O
100509,12,Metoprolol,B-Drug
100509,12,Omeprazole,O
100509,12,Levetiracetam,B-Drug
100509,12,Carbatrol,O
100509,12,Medications,O
100509,12,on,O
100509,12,transfer,O
100509,12,to,O
100509,12,[,O
100509,12,**Hospital,O
100509,12,Unit,O
100509,12,Name,O
100509,12,153**,O
100509,12,],O
100509,12,[,O
100509,12,**2172-8-27**,O
100509,12,],O
100509,12,:,O
100509,12,Furosemide,B-Drug
100509,12,10,O
100509,12,mg,O
100509,12,IV,O
100509,12,ONCE,O
100509,12,Duration,O
100509,12,:,O
100509,12,1,O
100509,12,Doses,O
100509,12,Carbamazepine,B-Drug
100509,12,900,O
100509,12,mg,O
100509,12,PO,O
100509,12,QPM,O
100509,12,Carbamazepine,B-Drug
100509,12,400,O
100509,12,mg,O
100509,12,PO,O
100509,12,QAM,O
100509,12,Artificial,B-Drug
100509,12,Tears,I-Drug
100509,12,Preserv,I-Drug
100509,12,.,I-Drug
100509,12,Free,I-Drug
100509,12,1-2,O
100509,12,DROP,O
100509,12,BOTH,O
100509,12,EYES,O
100509,12,PRN,O
100509,12,dry,B-Reason
100509,12,eyes,I-Reason
100509,12,Potassium,O
100509,12,Phosphate,O
100509,12,IV,O
100509,12,Sliding,O
100509,12,Scale,O
100509,12,Insulin,B-Drug
100509,12,SC,O
100509,12,Sliding,O
100509,12,Scale,O
100509,12,Insulin,B-Drug
100509,12,Regular,I-Drug
100509,12,10,O
100509,12,UNIT,O
100509,12,IV,O
100509,12,ONCE,O
100509,12,",",O
100509,12,Dextrose,B-Drug
100509,12,50,O
100509,12,%,O
100509,12,25,O
100509,12,gm,O
100509,12,IV,O
100509,12,ONCE,O
100509,12,Duration,O
100509,12,:,O
100509,12,1,O
100509,12,Doses,O
100509,12,08/20,O
100509,12,@,O
100509,12,0608,O
100509,12,Propofol,B-Drug
100509,12,20-50,O
100509,12,mcg/kg/min,O
100509,12,IV,O
100509,12,DRIP,O
100509,12,TITRATE,O
100509,12,TO,O
100509,12,moderate/heavy,B-Reason
100509,12,sedation,I-Reason
100509,12,Chlorhexidine,O
100509,12,Gluconate,O
100509,12,0.12,O
100509,12,%,O
100509,12,Oral,O
100509,12,Rinse,O
100509,12,15,O
100509,12,mL,O
100509,12,ORAL,O
100509,12,[,O
100509,12,**Hospital1,O
100509,12,**,O
100509,12,],O
100509,12,Hydrocortisone,B-Drug
100509,12,Na,O
100509,12,Succ,O
100509,12,.,O
100509,12,100,O
100509,12,mg,O
100509,12,IV,O
100509,12,Q8H,O
100509,12,Nicotine,B-Drug
100509,12,Patch,O
100509,12,14,O
100509,12,mg,O
100509,12,TD,O
100509,12,DAILY,O
100509,12,LeVETiracetam,B-Drug
100509,12,500,O
100509,12,mg,O
100509,12,IV,O
100509,12,BID,O
100509,12,Magnesium,B-Drug
100509,12,Sulfate,I-Drug
100509,12,IV,O
100509,12,Sliding,O
100509,12,Scale,O
100509,12,Calcium,B-Drug
100509,12,Gluconate,I-Drug
100509,12,IV,O
100509,12,Sliding,O
100509,12,Scale,O
100509,12,Potassium,B-Drug
100509,12,Chloride,I-Drug
100509,12,IV,O
100509,12,Sliding,O
100509,12,Scale,O
100509,12,Albuterol-Ipratropium,B-Drug
100509,12,[,O
100509,12,**1-10**,O
100509,12,],O
100509,12,PUFF,O
100509,12,IH,O
100509,12,Q6H,O
100509,12,Pantoprazole,B-Drug
100509,12,40,O
100509,12,mg,O
100509,12,IV,O
100509,12,Q24H,O
100509,12,Heparin,B-Drug
100509,12,5000,O
100509,12,UNIT,O
100509,12,SC,O
100509,12,TID,O
100509,12,Fentanyl,B-Drug
100509,12,Citrate,I-Drug
100509,12,25-100,O
100509,12,mcg,O
100509,12,IV,O
100509,12,Q6H,O
100509,12,:,O
100509,12,PRN,O
100509,12,Sedation,B-Reason
100509,12,Discharge,O
100509,12,Medications,O
100509,12,:,O
100509,12,Expired,O
100509,12,Discharge,O
100509,12,Disposition,O
100509,12,:,O
100509,12,Expired,O
100509,12,Discharge,O
100509,12,Diagnosis,O
100509,12,:,O
100509,12,Expired,O
100509,12,Discharge,O
100509,12,Condition,O
100509,12,:,O
100509,12,Expired,O
100509,12,Discharge,O
100509,12,Instructions,O
100509,12,:,O
100509,12,Expired,O
100509,12,Followup,O
100509,12,Instructions,O
100509,12,:,O
100509,12,Expired,O
100509,12,[,O
100509,12,**First,O
100509,12,Name8,O
100509,12,(,O
100509,12,NamePattern2,O
100509,12,),O
100509,12,**,O
100509,12,],O
100509,12,[,O
100509,12,**Last,O
100509,12,Name,O
100509,12,(,O
100509,12,NamePattern1,O
100509,12,),O
100509,12,2437**,O
100509,12,],O
100509,12,MD,O
100509,12,[,O
100509,12,**MD,O
100509,12,Number,O
100509,12,(,O
100509,12,1,O
100509,12,),O
100509,12,2438**,O
100509,12,],O
